Surf Away+ event brings adaptive sports to rare disease community
Ionis recently marked a decade of Surf Away+, a beach day of adaptive sports for people with neurological diseases, including ALS.| ALS News Today
Ionis recently marked a decade of Surf Away+, a beach day of adaptive sports for people with neurological diseases, including ALS.| ALS News Today
This year's ALS Nexus conference allowed the community to connect with each other, celebrate recent advances, and share hope for the future.| ALS News Today
No description.| ALS News Today
The European Commission has approved Qalsody to treat ALS patients in the EU whose disease is associated with mutations in the SOD1 gene.| ALS News Today
The FDA granted conditional approval to tofersen, now Qalsody, for the treatment of ALS associated with mutations in the SOD1 gene.| ALS News Today
Work using a new imaging technique found changes in how the SOD1 protein links with metal ions that seem key for how mutant SOD1 drives ALS.| ALS News Today
